Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chris H. J. Terhaard, M. D. , Ph. D. , Herman Lubsen, M. D. , Ph. D

Published byMercy Russell Modified over 7 years ago

Similar presentations

Presentation on theme: "Chris H. J. Terhaard, M. D. , Ph. D. , Herman Lubsen, M. D. , Ph. D"— Presentation transcript:

1 The role of radiotherapy in the treatment of malignant salivary gland tumors 
Chris H.J. Terhaard, M.D., Ph.D., Herman Lubsen, M.D., Ph.D., Coen R.N. Rasch, M.D., Ph.D., Peter C. Levendag, M.D., Ph.D., Hans H.À.M. Kaanders, M.D., Ph.D., Reineke E. Tjho-Heslinga, M.D., Piet L.A. van Den Ende, M.D., Fred Burlage, M.D.  International Journal of Radiation Oncology • Biology • Physics  Volume 61, Issue 1, Pages (January 2005) DOI: /j.ijrobp

2 Fig. 1 Positive neck nodes (%) at first presentation, according to site and level (I–V). International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

3 Fig. 2 Interval between surgery and postoperative radiotherapy.
International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

4 Fig. 3 Dose distribution postoperative local radiation field.
International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

5 Fig. 4 Local recurrence-free survival depending on T status and therapy. (S+RT = surgery plus radiotherapy.) International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

6 Fig. 5 Local recurrence-free survival depending on status of resection margins and therapy. (S+RT = surgery plus radiotherapy; compl. = complete; incompl. = incomplete.) International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

7 Fig. 6 Local recurrence-free survival and interval surgery and postoperative radiotherapy. International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

8 Fig. 7 Radiotherapy after incomplete resection: dose–response (*linear quadratic–dose equivalent, potential doubling time [Tpot] = 5) for 5-year local control. (n.s. = not significant.) International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

9 Fig. 8 Primary radiotherapy: local recurrence-free survival depending on tumor dose. International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

Download ppt "Chris H. J. Terhaard, M. D. , Ph. D. , Herman Lubsen, M. D. , Ph. D"

Similar presentations

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time Emma Liu, MM, Pablo Santibáñez, MM, Martin L. Puterman, PhD,

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time Emma Liu, MM, Pablo Santibáñez, MM, Martin L. Puterman, PhD,
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.
Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.

Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.
Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,

Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,
The Case for Prostate Brachytherapy in the Affordable Care Act Era

The Case for Prostate Brachytherapy in the Affordable Care Act Era
Benjamin D. Rosenbluth, M. D. , Victoria Serrano, B. S

Benjamin D. Rosenbluth, M. D. , Victoria Serrano, B. S
The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation.

The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation.
The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study  Alan M. Nichol,

The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study  Alan M. Nichol,
Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 
Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I/II Trial  Leena Kankaanranta, M.D.,

Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I/II Trial  Leena Kankaanranta, M.D.,
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.

Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.
Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.
Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated  Michael D. Chuong,

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated  Michael D. Chuong,
Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,

Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,
Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation  Rahul R. Parikh, M.D., Bruce.

Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation  Rahul R. Parikh, M.D., Bruce.
The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy  C.

The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy  C.

Similar presentations

Ads by Google